Prof. Dr. Regine Heilbronn

Gastprofessorin an der Charité – Universitätsmedizin Berlin und CEO von EpiBlok Therapeutics, Bayer Co.Lab Berlin

Position at the time of the most recent service

Person-specific ID linked to research outputs and biographical data
Open-source database with research outputs, bibliometric indicators, and institutional affiliations
Loading...Loading...